Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 1—January 2006
Research

Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore

Vernon J. Lee*Comments to Author , Kai Hong Phua†, Mark I. Chen*, Angela Chow‡, Stefan Ma‡, Kee Tai Goh‡, and Yee Sin Leo*
Author affiliations: *Tan Tock Seng Hospital, Singapore; †National University of Singapore, Singapore; ‡Ministry of Health, Singapore

Main Article

Figure 3

Proportion of decisions for treatment or 24 weeks prophylaxis, by case-fatality rate.

Figure 3. Proportion of decisions for treatment or 24 weeks prophylaxis, by case-fatality rate.

Main Article

1"Dominate" is a term used in cost-effectiveness analyses and refers to a strategy that is both more efficacious and less costly than another strategy.

Page created: February 16, 2012
Page updated: February 16, 2012
Page reviewed: February 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external